Previous prospective and retrospective trials have failed to demonstra
te the best treatment approach for patients with brain metastases. As
a result, fractionated whole brain radiotherapy (WBRT) has been the ma
instay of treatment for several decades. However, with improved surgic
al techniques and the advent of radiosurgical procedures to treat sing
le and multiple metastases, the continued value of WBRT is in question
. This is particularly true in the treatment of a favorable patient su
bset where the risks of long-term morbidity need to be addressed. This
article reviews the trials of the Radiation Therapy Oncology Group (R
TOG) and other select radiotherapy brain metastases trials, and compar
es their morbidities and outcomes to surgical and radiosurgical techni
ques. It is unfortunate that the inherent selection bias in most retro
spective studies makes comparisons difficult. Therefore, to better und
erstand the roles of WBRT, surgery, and radiosurgery in the treatment
of brain metastases, additional randomized studies need to be conducte
d on homogeneous patient groups. (C) 1998 Wiley-Liss, Inc.